Relmada Therapeutics (RLMD) Cash & Current Investments (2012 - 2026)
Relmada Therapeutics' Cash & Current Investments came in at $217.73 million for Q2 2026, up 955.9% from $20.62 million a year earlier but down 6.9% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Cash & Current Investments (2012 - 2026) Analysis & Trends
At the end of FY2025, Relmada Therapeutics' Cash & Current Investments was $93.01 million, up 107.1% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $44.91 million in FY2024 (-53.4%), $96.32 million in FY2023 (-35.1%), $148.32 million in FY2022 (-30.0%) and $211.91 million in FY2021 (+81.0%).
- The five-year range for quarterly Cash & Current Investments is $13.89 million (Q3 2025) to $233.96 million (Q1 2026).
- Year-over-year, Cash & Current Investments has increased for three consecutive quarters, with growth averaging 189.1% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 955.9%), and the weakest in Q3 2025 (a decline of 74.3%).
- Business Quant data shows RLMD's Cash & Current Investments at $233.96 million (Q1 2026), $93.01 million (Q4 2025) and $13.89 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,126.20 Bn | 1,094.78 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 633.36 Bn | 553.22 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.51 Bn | 477.62 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 357.58 Bn | 311.96 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 289.65 Bn | 253.64 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 264.97 Bn | 238.66 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.69 Bn | 193.09 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.48 Bn | 168.68 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Relmada Therapeutics | 369.44 Mn | -189.15 Mn | - | 217.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217.73 Mn |
| Mar 31, 2026 | 233.96 Mn |
| Dec 31, 2025 | 93.01 Mn |
| Sep 30, 2025 | 13.89 Mn |
| Jun 30, 2025 | 20.62 Mn |
| Mar 31, 2025 | 27.06 Mn |
| Dec 31, 2024 | 44.91 Mn |
| Sep 30, 2024 | 54.12 Mn |
| Jun 30, 2024 | 70.44 Mn |
| Mar 31, 2024 | 83.61 Mn |
| Dec 31, 2023 | 96.32 Mn |
| Sep 30, 2023 | 106.27 Mn |
| Jun 30, 2023 | 118.53 Mn |
| Mar 31, 2023 | 132.44 Mn |
| Dec 31, 2022 | 148.32 Mn |
| Sep 30, 2022 | 184.15 Mn |
| Jun 30, 2022 | 211.96 Mn |
| Mar 31, 2022 | 220.65 Mn |
| Dec 31, 2021 | 211.91 Mn |
| Sep 30, 2021 | 88.09 Mn |
API Access
Relmada Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();